| __timestamp | Apellis Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 8379522 | 152500000 |
| Thursday, January 1, 2015 | 13730311 | 187800000 |
| Friday, January 1, 2016 | 22978599 | 184000000 |
| Sunday, January 1, 2017 | 40303878 | 167700000 |
| Monday, January 1, 2018 | 105285576 | 218600000 |
| Tuesday, January 1, 2019 | 220968770 | 187400000 |
| Wednesday, January 1, 2020 | 299921000 | 177700000 |
| Friday, January 1, 2021 | 420869000 | 122000000 |
| Saturday, January 1, 2022 | 387236000 | 123100000 |
| Sunday, January 1, 2023 | 354387000 | 122500000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Apellis Pharmaceuticals, Inc. has demonstrated a robust commitment to R&D, with a staggering 4,000% increase in spending from 2014 to 2023. This surge underscores their focus on pioneering treatments and maintaining a competitive edge.
Conversely, Perrigo Company plc has shown a more conservative approach, with R&D expenses peaking in 2018 and subsequently declining by approximately 44% by 2023. This trend may reflect a strategic pivot towards optimizing existing product lines or exploring cost efficiencies.
The contrasting R&D trajectories of these two companies highlight differing strategic priorities in the pharmaceutical sector. As Apellis continues to invest heavily in innovation, Perrigo's strategy may suggest a focus on market consolidation and operational efficiency.
Johnson & Johnson or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Investment: Pfizer Inc. vs Apellis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and Perrigo Company plc
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.
Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Apellis Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Analyzing R&D Budgets: Perrigo Company plc vs Protagonist Therapeutics, Inc.
Analyzing R&D Budgets: Perrigo Company plc vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Perrigo Company plc vs Dynavax Technologies Corporation